The Stereotactic Surgery Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Stereotactic Surgery Devices Market:
https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report
According to The Business Research Company’s Stereotactic Surgery Devices Global Market Report 2024, The stereotactic surgery devices market size has grown steadily in recent years. It will grow from $21.43 billion in 2023 to $22.41 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to shift towards minimally invasive procedures, integration of robotics and automation, increased demand for precision and accuracy, improved safety profiles.
The stereotactic surgery devices market size is expected to see steady growth in the next few years. It will grow to $27.21 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to rising cases of cancer, ai and machine learning integration, expansion to new medical specialties, rise in geriatric population, customization and personalization in treatments. Major trends in the forecast period include precision and accuracy improvement, miniaturization of devices, robotics and automation, personalized treatment approaches, expanded applications and procedures.
The increasing number of Parkinson’s disease and epilepsy are expected to boost the growth of the stereotactic surgical device market going forward. Parkinson’s disease is a neurodegenerative illness that causes involuntary shaking, sluggish movement, and stiff, inflexible muscles, whereas epilepsy is a neurological ailment that affects the brain and renders patients more susceptible to experiencing recurring, unprovoked seizures. Stereotactic surgical devices are used to treat movement disorders, epilepsy, pain, and psychiatry, as well as Parkinson’s disease. For instance, as per the study revealed by the Parkinson’s Foundation, a New York-based national nonprofit organization, in 2022, in the United States, over 90,000 people will be diagnosed with Parkinson’s disease each year. This is a 50% rise from the previously expected yearly rate of 60,000 diagnoses. Parkinson’s disease (PD) affects almost a million people in the United States. By 2030, to increase to 1.2 million. Therefore, increasing cases of Parkinson’s disease and epilepsy are driving the growth of the stereotactic surgical device market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp
The stereotactic surgery devices market covered in this report is segmented –
1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife
2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications
3) By End User: Hospitals, Laboratories
Technological advancements have emerged as the key trend gaining popularity in the stereotactic surgical device market. Major companies operating in the stereotactic surgical device market are developing innovative technologies to strengthen their position in the market. For instance, in May 2023, Brainlab, a Germany-based medical technology company has launched a new product called ExacTrac Dynamic Surface, which is a surface guided radiation therapy (SGRT) patient tracking and positioning system. The system offers high-speed thermal surface tracking technology combined with an update of ExacTrac X-ray monitoring, which increases versatility and accuracy in patient positioning and monitoring for various treatments, including cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system emits a structured blue light pattern onto the patient surface that is acquired by two 3D cameras, and each surface point is augmented with a thermal signature, which is registered by the third in-unit camera.
The stereotactic surgery devices market report table of contents includes:
1. Executive Summary
2. Stereotactic Surgery Devices Market Characteristics
3.Stereotactic Surgery Devices Market Trends And Strategies
4.Stereotactic Surgery Devices market analysis
5. Stereotactic Surgery Devices Market Size And Growth
6. Stereotactic Surgery Devices Segmentation
7. Stereotactic Surgery Devices Regional And Country Analysis
.
.
.
27.Stereotactic Surgery Devices Competitive Landscape And Company Profiles
28.Stereotactic Surgery Devices Key Mergers And Acquisitions
29.Stereotactic Surgery Devices Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Alliance Oncology
- Micromar Industria Commercio Ltda.
- Adeor Medical AG
- Monteris Medical Holding AG
- Inomed Medizintechnik GmbH
- Ion Beam Applications S.A. (IBA)
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
